SR-BI was shown to play a role in this process, such that its inhibition reduced cancer cell proliferation (Pussinen et al., 2000; Cao et al., 2004; Leon et al., 2010; Julovi et al., 2016). This evidence concerns the gene SCARB1 and cancer.